Paratek Pharmaceuticals, Inc.: meeting of 18 Sep 2023

Votes reported on Form N-PX, item by item

86 Form N-PX filers reported votes at the Paratek Pharmaceuticals, Inc. meeting of 18 Sep 2023. Their records fall into 6 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

5 vote records from 3 filers. 0 of the 2 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

33.3% for33.3% against33.3% other0.0% against management3 filers93.2% for6.8% against0.0% against management10,734 reported shares

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on pay tied to a merger or sale

93 vote records from 79 filers. 54 of the 77 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.

27.8% for69.6% against2.5% other70.1% against management79 filers50.7% for49.3% against49.3% against management14,990,893 reported shares

EXTRAORDINARY TRANSACTIONSIssuer

EXTRAORDINARY TRANSACTIONS: management items

Management items in this category are shown together; filers word and number them differently.

18 vote records from 13 filers. 0 of the 13 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management13 filers100.0% for0.0% against0.0% against management2,216,313 reported shares, counted once per item in this group

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

4 vote records from 4 filers. 0 of the 4 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management4 filers100.0% for0.0% against0.0% against management65,500 reported shares, counted once per item in this group

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

4 vote records from 4 filers. 0 of the 4 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management4 filers100.0% for0.0% against0.0% against management65,500 reported shares, counted once per item in this group

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

40 vote records from 26 filers. 5 of the 26 filers that marked the item either way voted against management.

80.8% for19.2% against19.2% against management26 filers59.0% for41.0% against41.0% against management13,124,137 reported shares, counted once per item in this group

How the largest families voted

Family	2. Merger pay
Vanguard	For
BlackRock and iShares	Against *
Fidelity	Against *
State Street and SPDR	Against *
Equitable	Against *
Charles Schwab	Against *
John Hancock and Manulife	Against *
Morgan Stanley, Eaton Vance and Calvert	Against *
Goldman Sachs	Against *
PGIM and Prudential	Against *
Northern Trust and FlexShares	Against *
SEI	Against *
Victory Capital	Against *
Guggenheim and Rydex	Against *
BNY Mellon	Against *
Baird	Against *

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Paratek Pharmaceuticals, Inc. meeting?

86 Form N-PX filers reported votes at the meeting of 18 Sep 2023. On say-on-pay, 0 of 2 voted against management (0.0%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Paratek Pharmaceuticals, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Paratek Pharmaceuticals, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Paratek Pharmaceuticals, Inc. with a meeting date within three days of 18 Sep 2023. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.